USPSTF: Prostate Ca Screening Should Be Individual Decision

USPSTF: Prostate Ca Screening Should Be Individual Decision

Universal screening not recommended for high-risk groups

In finalizing its draft recommendations for prostate cancer screening in men ages 55 to 69, the U.S. Preventive Services Task Force (USPSTF) has put itself broadly in alignment with guidelines from other organizations.

The USPSTF now recommends that for this age group, the decision to be screened for prostate cancer with prostate-specific antigen (PSA)-based testing should be an individual one, reported USPSTF Vice Chair Alex H. Krist, MD, MPH, of the Virginia Commonwealth University in Richmond, and colleagues in JAMA.

Read more about prostate cancer screening

Submit a Comment

Your email address will not be published. Required fields are marked *

Anatara Medicine

Subscribe To Our Newsletter

Join our mailing list to receive the latest news and updates from Dr. Ahvie Herskowitz and Anatara Medicine.

Thank you for your interest in Anatara Medicine. You have been added to our list.